Beijing Shenogen Biomedical Co., Ltd   Report issue

For profit Phase 3
Founded: Beijing China (2010)

Organization Overview

First Clinical Trial
2010
NCT01278810
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Beijing Shenogen Biomedical Co., Ltd